Advisor Net Financial, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Advisor Net Financial, Inc

  • $1.05 Billion
  • Q2 2024

A detailed history of Advisor Net Financial, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 69 shares of REGN stock, worth $79,125. This represents 0.01% of its overall portfolio holdings.

Number of Shares
69
Previous 69 -0.0%
Holding current value
$79,125
Previous $66,000 9.09%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024
SELL
$902.69 - $993.35 $30,691 - $33,773
-34 Reduced 33.01%
69 $66,000
Q4 2023

Jan 19, 2024
SELL
$775.18 - $881.7 $15,503 - $17,634
-20 Reduced 16.26%
103 $90,000
Q3 2023

Oct 12, 2023
SELL
$692.45 - $844.37 $83,786 - $102,168
-121 Reduced 49.59%
123 $101,000
Q2 2023

Jul 14, 2023
SELL
$700.03 - $830.35 $8,400 - $9,964
-12 Reduced 4.69%
244 $175,000
Q1 2023

Apr 28, 2023
BUY
$680.49 - $826.97 $680 - $826
1 Added 0.39%
256 $210,000
Q4 2022

Jan 13, 2023
BUY
$705.89 - $766.39 $14,823 - $16,094
21 Added 8.97%
255 $0
Q3 2022

Oct 04, 2022
SELL
$573.97 - $724.32 $2,869 - $3,621
-5 Reduced 2.09%
234 $161,000
Q2 2022

Jul 07, 2022
BUY
$548.35 - $738.84 $66,898 - $90,138
122 Added 104.27%
239 $141,000
Q1 2022

Apr 14, 2022
SELL
$595.12 - $698.43 $7,736 - $9,079
-13 Reduced 10.0%
117 $82,000
Q4 2021

Jan 19, 2022
BUY
$543.48 - $670.97 $1,086 - $1,341
2 Added 1.56%
130 $82,000
Q3 2021

Oct 15, 2021
BUY
$574.03 - $680.96 $574 - $680
1 Added 0.79%
128 $77,000
Q2 2021

Jul 06, 2021
SELL
$472.8 - $558.54 $8,037 - $9,495
-17 Reduced 11.81%
127 $71,000
Q1 2021

Apr 14, 2021
SELL
$446.73 - $548.2 $7,147 - $8,771
-16 Reduced 10.0%
144 $68,000
Q4 2020

Feb 04, 2021
SELL
$478.3 - $607.98 $19,610 - $24,927
-41 Reduced 20.4%
160 $77,000
Q3 2020

Nov 06, 2020
BUY
$544.75 - $658.21 $13,618 - $16,455
25 Added 14.2%
201 $113,000
Q2 2020

Aug 26, 2020
BUY
$493.32 - $643.92 $36,999 - $48,294
75 Added 74.26%
176 $110,000
Q1 2020

May 14, 2020
BUY
$336.18 - $494.43 $7,059 - $10,383
21 Added 26.25%
101 $49,000
Q3 2019

Oct 23, 2019
SELL
$273.46 - $318.39 $273 - $318
-1 Reduced 1.23%
80 $22,000
Q2 2019

Jul 15, 2019
BUY
$299.6 - $414.82 $1,198 - $1,659
4 Added 5.19%
81 $25,000
Q4 2018

Feb 08, 2019
BUY
$335.82 - $403.04 $17,462 - $20,958
52 Added 208.0%
77 $29,000
Q4 2017

Feb 27, 2018
BUY
$358.63 - $469.95 $8,965 - $11,748
25
25 $9,000

Others Institutions Holding REGN

# of Institutions
1,461
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $123B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email